This site is intended only for healthcare professionals resident in the Republic of Ireland
The Popit Sense device, together with the Popit app, could support the care and well-being of your patients in a whole new way.
Popit Sense is a sensor platform that has been CE marked as a radio equipment device. Popit app is classified as a Software Medical Device according to the EU Medical Device Regulation. The Popit Solution has been clinically tested and validated.
Popit respects the privacy of the user. Popit Sense and its related app does not collect identifiable data.
If a tablet is removed and Bluetooth is turned off, the information about the removal may not be immediately reported to the app. This could result in the user receiving one unnecessary reminder. Modern versions of Bluetooth do not use a lot of energy, generally less than 1% of total battery consumption.
When the device battery charge drops below 20%, the app will suggest once per day to change the battery. The CR2032 coin cell battery can be easily replaced by the user.
Yes. However, it is advisable to travel with both the Popit Sense device and the Popit Protective Sleeve. If a dose is taken while the smartphone is in aeroplane mode (Bluetooth off), the app will be updated as soon as Bluetooth is switched on again. In addition, the user will need to ensure that they set the medication reminder times to the time zone of the destination country.
From time to time, the user will receive messages in the app. For example, messages to confirm to them that they are taking their medications, or to remind them of the importance of taking their medication as prescribed.
*The studies referenced in this section are from a general knowledge perspective and do not pertain to the use of Popit. The views, thoughts and opinions expressed in the text are those of the authors of the referenced papers and not those of Popit or Pfizer.
Pfizer has no influence over the function or content of the Popit Solution, or the programme contained therein. Pfizer supports Popit financially, in the context of a collaboration to make the Popit Solution available to patients within the Republic of Ireland.
Learn more about Pfizer's treatment options in Gastroenterology
Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
Adverse events should also be reported to Pfizer Medical Information on 1800 633 363
Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.
This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie
This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.
Copyright © 2023 Pfizer Limited. All rights reserved.
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023